Investigational direct-acting antivirals in hepatitis C treatment: the latest drugs in clinical development.
about
Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis CAntiviral Nucleotide Incorporation by Recombinant Human Mitochondrial RNA Polymerase Is Predictive of Increased In Vivo Mitochondrial Toxicity Risk.Black blood T1rho MR imaging may diagnose early stage liver fibrosis: a proof-of-principle study with rat biliary duct ligation modelNS5B polymerase inhibitors in phase II clinical trials for HCV infection.
P2860
Investigational direct-acting antivirals in hepatitis C treatment: the latest drugs in clinical development.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Investigational direct-acting ...... drugs in clinical development.
@ast
Investigational direct-acting ...... drugs in clinical development.
@en
type
label
Investigational direct-acting ...... drugs in clinical development.
@ast
Investigational direct-acting ...... drugs in clinical development.
@en
prefLabel
Investigational direct-acting ...... drugs in clinical development.
@ast
Investigational direct-acting ...... drugs in clinical development.
@en
P2093
P2860
P50
P1476
Investigational direct-acting ...... drugs in clinical development
@en
P2093
Antonio Riccardo Buonomo
Guglielmo Borgia
Ivan Gentile
P2860
P304
P356
10.1517/13543784.2016.1161023
P407
P577
2016-03-21T00:00:00Z